[EN] INHIBITORS OF EZH2<br/>[FR] INHIBITEURS DE L'EZH2
申请人:LILLY CO ELI
公开号:WO2017035060A1
公开(公告)日:2017-03-02
The present invention relates to compounds that inhibit activity of the histone lysine methyltransferase, Enhancer of Zeste Homolog 2 (EZH2), pharmaceutical compositions comprising the compounds, and methods of using the compounds to treat cancer, such as hematologic and solid tumors.
本发明涉及抑制组蛋白赖氨酸甲基转移酶Enhancer of Zeste Homolog 2(EZH2)活性的化合物,包括这些化合物的药物组合物,以及使用这些化合物治疗癌症,如血液学和实体肿瘤的方法。
3,4-Di-Substituted Cyclobutene-1,2-Diones as CXC-Chemokine Receptor Ligands
申请人:Taveras Arthur G.
公开号:US20110213029A1
公开(公告)日:2011-09-01
There are disclosed compounds of the formula
or a pharmaceutically acceptable salt or solvate thereof which are useful for the treatment of chemokine-mediated diseases such as acute and chronic inflammatory disorders and cancer.